PF478 DOES ESCALATED BEACOP‐DACARBAZINE DO THE SAME AS ESCALATED BEACOP‐PROCARBAZINE FOR UNFAVORABLE HODGKIN'S LYMPHOMA? von Mansouri, R., Kacem, K., Jabr, D., Bchir, M., Aissaoui, L., Berred, E., Kefi, S., Ben Néji, H., Achour, M., Ben Abdennebi, Y., Bahri, M., Meddeb, B., Ben Lakhal, R.

Volltext

PF478 DOES ESCALATED BEACOP‐DACARBAZINE DO THE SAME AS ESCALATED BEACOP‐PROCARBAZINE FOR UNFAVORABLE HODGKIN'S LYMPHOMA? von Mansouri, R., Kacem, K., Jabr, D., Bchir, M., Aissaoui, L., Berred, E., Kefi, S., Ben Néji, H., Achour, M., Ben Abdennebi, Y., Bahri, M., Meddeb, B., Ben Lakhal, R.

Volltext

PB1824: IMPACT OF DAY 15 BONE MARROW ASPIRATION ON PREDICTION OF COMPLETE REMISSION AND RELAPSE IN ACUTE MYELOID LEUKEMIA von Kharrat, R., Charef, O., Berred, R., Chabaane, A., Sammoud, S., Bchir, M., Ben Lakhal, F., Feki, S., Borgi, W., Gouider, E., Amouri, A., Ayed, W., Ben Neji, H., Meddeb, B.

Volltext